Diva Sze-Ming Chan is a prominent inventor based in San Francisco, CA, known for her significant contributions to the field of protein kinase modulation. With a total of nine patents to her name, she has made remarkable strides in developing compounds that influence cellular activities.

Latest Patents

Her latest patents focus on C-met modulators and methods of use. The inventions provide compounds for modulating protein kinase enzymatic activity, which in turn affects cellular activities such as proliferation, differentiation, programmed cell death, migration, and chemoinvasion. Specifically, her work involves quinazolines and quinolines that inhibit, regulate, and modulate kinase receptors, particularly c-Met, KDR, c-Kit, flt-3, and flt-4. These inventions also include methods for making these compounds and compositions that can be used to treat kinase-dependent diseases and conditions.

Career Highlights

Diva has worked with notable companies such as Exelixis, Inc. and Exelixus, Inc., where she has applied her expertise in the development of innovative therapeutic solutions. Her work has been instrumental in advancing the understanding of kinase-related pathways and their implications in various diseases.

Collaborations

Diva has collaborated with esteemed colleagues, including Lynne Canne Bannen and Richard George Khoury, contributing to a rich environment of innovation and research.

Conclusion

Diva Sze-Ming Chan's work in protein kinase modulation exemplifies the impact of innovative thinking in the field of biotechnology. Her contributions continue to pave the way for advancements in treating kinase-dependent diseases and conditions.

This text is generated by artificial intelligence and may not be accurate.